Selected research
Industry Research
Synthetic Injectable Bone Graft Industry Research Report 2026
Market perspective
The global Synthetic Injectable Bone Graft market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Synthetic Injectable Bone Graft market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Synthetic Injectable Bone Graft market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Synthetic Injectable Bone Graft market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Synthetic Injectable Bone Graft include Baxter, Zimmer Biomet, Xtant Medical, Stryker (Wright Medical), SeaSpine, ORD, Medtronic, Graftys and DePuy Synthes, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Synthetic Injectable Bone Graft market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Synthetic Injectable Bone Graft.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Synthetic Injectable Bone Graft Market by Company
Baxter
Zimmer Biomet
Xtant Medical
Stryker (Wright Medical)
SeaSpine
ORD
Medtronic
Graftys
DePuy Synthes
BONESUPPORT
Biomatlante
Biocomposites
Anika
Synthetic Injectable Bone Graft Segment by Type
Hydroxyapatite
Calcium Phosphate
Others
Synthetic Injectable Bone Graft Segment by Application
Hospital
Clinic
Synthetic Injectable Bone Graft Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Injectable Bone Graft market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Synthetic Injectable Bone Graft and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Injectable Bone Graft.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Synthetic Injectable Bone Graft companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hydroxyapatite
- Calcium Phosphate
- Others
Applications
- Hospital
- Clinic
Companies covered
- Baxter
- Zimmer Biomet
- Xtant Medical
- Stryker (Wright Medical)
- SeaSpine
- ORD
- Medtronic
- Graftys
- DePuy Synthes
- BONESUPPORT
- Biomatlante
- Biocomposites
- Anika
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Synthetic Injectable Bone Graft by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hydroxyapatite
- 2.2.3 Calcium Phosphate
- 2.2.4 Others
- 2.3 Synthetic Injectable Bone Graft by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Synthetic Injectable Bone Graft Breakdown Data by Type
- 3.1 Global Synthetic Injectable Bone Graft Historic Market Size by Type (2021-2026)
- 3.2 Global Synthetic Injectable Bone Graft Forecasted Market Size by Type (2027-2032)
4 Synthetic Injectable Bone Graft Breakdown Data by Application
- 4.1 Global Synthetic Injectable Bone Graft Historic Market Size by Application (2021-2026)
- 4.2 Global Synthetic Injectable Bone Graft Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Synthetic Injectable Bone Graft Market Perspective (2021-2032)
- 5.2 Global Synthetic Injectable Bone Graft Growth Trends by Region
- 5.2.1 Global Synthetic Injectable Bone Graft Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Synthetic Injectable Bone Graft Historic Market Size by Region (2021-2026)
- 5.2.3 Synthetic Injectable Bone Graft Forecasted Market Size by Region (2027-2032)
- 5.3 Synthetic Injectable Bone Graft Market Dynamics
- 5.3.1 Synthetic Injectable Bone Graft Industry Trends
- 5.3.2 Synthetic Injectable Bone Graft Market Drivers
- 5.3.3 Synthetic Injectable Bone Graft Market Challenges
- 5.3.4 Synthetic Injectable Bone Graft Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Synthetic Injectable Bone Graft Players by Revenue
- 6.1.1 Global Top Synthetic Injectable Bone Graft Players by Revenue (2021-2026)
- 6.1.2 Global Synthetic Injectable Bone Graft Revenue Market Share by Players (2021-2026)
- 6.2 Global Synthetic Injectable Bone Graft Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Synthetic Injectable Bone Graft Head Office and Area Served
- 6.4 Global Synthetic Injectable Bone Graft Players, Product Type & Application
- 6.5 Global Synthetic Injectable Bone Graft Manufacturers Established Date
- 6.6 Global Synthetic Injectable Bone Graft Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Synthetic Injectable Bone Graft Market Size (2021-2032)
- 7.2 North America Synthetic Injectable Bone Graft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Synthetic Injectable Bone Graft Market Size by Country (2021-2026)
- 7.4 North America Synthetic Injectable Bone Graft Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Synthetic Injectable Bone Graft Market Size (2021-2032)
- 8.2 Europe Synthetic Injectable Bone Graft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Synthetic Injectable Bone Graft Market Size by Country (2021-2026)
- 8.4 Europe Synthetic Injectable Bone Graft Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Synthetic Injectable Bone Graft Market Size (2021-2032)
- 9.2 Asia-Pacific Synthetic Injectable Bone Graft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Synthetic Injectable Bone Graft Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Synthetic Injectable Bone Graft Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Synthetic Injectable Bone Graft Market Size (2021-2032)
- 10.2 South America Synthetic Injectable Bone Graft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Synthetic Injectable Bone Graft Market Size by Country (2021-2026)
- 10.4 South America Synthetic Injectable Bone Graft Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Synthetic Injectable Bone Graft Market Size (2021-2032)
- 11.2 Middle East & Africa Synthetic Injectable Bone Graft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Synthetic Injectable Bone Graft Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Synthetic Injectable Bone Graft Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Baxter
- 12.1.1 Baxter Company Information
- 12.1.2 Baxter Business Overview
- 12.1.3 Baxter Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.1.4 Baxter Synthetic Injectable Bone Graft Product Portfolio
- 12.1.5 Baxter Recent Developments
- 12.2 Zimmer Biomet
- 12.2.1 Zimmer Biomet Company Information
- 12.2.2 Zimmer Biomet Business Overview
- 12.2.3 Zimmer Biomet Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.2.4 Zimmer Biomet Synthetic Injectable Bone Graft Product Portfolio
- 12.2.5 Zimmer Biomet Recent Developments
- 12.3 Xtant Medical
- 12.3.1 Xtant Medical Company Information
- 12.3.2 Xtant Medical Business Overview
- 12.3.3 Xtant Medical Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.3.4 Xtant Medical Synthetic Injectable Bone Graft Product Portfolio
- 12.3.5 Xtant Medical Recent Developments
- 12.4 Stryker (Wright Medical)
- 12.4.1 Stryker (Wright Medical) Company Information
- 12.4.2 Stryker (Wright Medical) Business Overview
- 12.4.3 Stryker (Wright Medical) Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.4.4 Stryker (Wright Medical) Synthetic Injectable Bone Graft Product Portfolio
- 12.4.5 Stryker (Wright Medical) Recent Developments
- 12.5 SeaSpine
- 12.5.1 SeaSpine Company Information
- 12.5.2 SeaSpine Business Overview
- 12.5.3 SeaSpine Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.5.4 SeaSpine Synthetic Injectable Bone Graft Product Portfolio
- 12.5.5 SeaSpine Recent Developments
- 12.6 ORD
- 12.6.1 ORD Company Information
- 12.6.2 ORD Business Overview
- 12.6.3 ORD Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.6.4 ORD Synthetic Injectable Bone Graft Product Portfolio
- 12.6.5 ORD Recent Developments
- 12.7 Medtronic
- 12.7.1 Medtronic Company Information
- 12.7.2 Medtronic Business Overview
- 12.7.3 Medtronic Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.7.4 Medtronic Synthetic Injectable Bone Graft Product Portfolio
- 12.7.5 Medtronic Recent Developments
- 12.8 Graftys
- 12.8.1 Graftys Company Information
- 12.8.2 Graftys Business Overview
- 12.8.3 Graftys Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.8.4 Graftys Synthetic Injectable Bone Graft Product Portfolio
- 12.8.5 Graftys Recent Developments
- 12.9 DePuy Synthes
- 12.9.1 DePuy Synthes Company Information
- 12.9.2 DePuy Synthes Business Overview
- 12.9.3 DePuy Synthes Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.9.4 DePuy Synthes Synthetic Injectable Bone Graft Product Portfolio
- 12.9.5 DePuy Synthes Recent Developments
- 12.10 BONESUPPORT
- 12.10.1 BONESUPPORT Company Information
- 12.10.2 BONESUPPORT Business Overview
- 12.10.3 BONESUPPORT Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.10.4 BONESUPPORT Synthetic Injectable Bone Graft Product Portfolio
- 12.10.5 BONESUPPORT Recent Developments
- 12.11 Biomatlante
- 12.11.1 Biomatlante Company Information
- 12.11.2 Biomatlante Business Overview
- 12.11.3 Biomatlante Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.11.4 Biomatlante Synthetic Injectable Bone Graft Product Portfolio
- 12.11.5 Biomatlante Recent Developments
- 12.12 Biocomposites
- 12.12.1 Biocomposites Company Information
- 12.12.2 Biocomposites Business Overview
- 12.12.3 Biocomposites Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.12.4 Biocomposites Synthetic Injectable Bone Graft Product Portfolio
- 12.12.5 Biocomposites Recent Developments
- 12.13 Anika
- 12.13.1 Anika Company Information
- 12.13.2 Anika Business Overview
- 12.13.3 Anika Revenue in Synthetic Injectable Bone Graft Business (2021-2026)
- 12.13.4 Anika Synthetic Injectable Bone Graft Product Portfolio
- 12.13.5 Anika Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst